Early Aggressive Invasive Intervention for Atrial Fibrillation
Status:
Active, not recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The EARLY-AF study is centered on an evaluation of the impact of the early invasive
management of Atrial Fibrillation. The primary goal of the study is to evaluate the clinical
effectiveness of an early invasive approach. Specifically, the investigators are aiming to
evaluate if PVI performed with the Arctic Front cryoballoon is superior to AAD as first-line
therapy in preventing atrial arrhythmia recurrences (arrhythmia related symptoms,
hospitalisations, and health care utilization).
Phase:
N/A
Details
Lead Sponsor:
Jason Andrade
Collaborators:
Baylis Medical Company Medtronic Ottawa Heart Institute Research Corporation